1. bookVolumen 14 (2021): Edición 1 (June 2021)
Detalles de la revista
License
Formato
Revista
eISSN
1313-9053
Primera edición
08 Sep 2014
Calendario de la edición
2 veces al año
Idiomas
Inglés
Acceso abierto

Growth Hormone Treatment: First Results of the Partnership Program for the Establishment of a Growth Center at the University Clinic of Pediatrics –Pleven

Publicado en línea: 12 Jul 2021
Volumen & Edición: Volumen 14 (2021) - Edición 1 (June 2021)
Páginas: 62 - 69
Recibido: 10 Jan 2021
Aceptado: 22 Apr 2021
Detalles de la revista
License
Formato
Revista
eISSN
1313-9053
Primera edición
08 Sep 2014
Calendario de la edición
2 veces al año
Idiomas
Inglés

1. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr, 2013;102(8):787-96.10.1111/apa.12266 Search in Google Scholar

2. Blizzard RM. History of growth hormone therapy. Indian J Pediatr, 2012;79(1):87-91.10.1007/s12098-011-0609-4 Search in Google Scholar

3. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr, 1985;107(1):10-2.10.1016/S0022-3476(85)80604-1 Search in Google Scholar

4. Peneva L. Hyposomatotropism in childhood and adolescence, Dissertation, Medical Academy -Sofia, 1984;191-83. Search in Google Scholar

5. Peneva L, Kazakova K, Stefanova E, Stoeva I. Treatment of children with hyposomatotropism with recombinant human growth hormone Norditropin. Paediatrics, 1996;36-41. Search in Google Scholar

6. Iotova V. Effect of low weight and short stature at birth on postnatal growh and some markers of increased cardiovascular and metabolic risk in adolescents, Dissertation, Medical University -Varna, 2003. Search in Google Scholar

7. Brook CGD, Clayton P, Brown R, Brook’s Clinical Pediatric Endocrinology. 2011: Wiley.10.1002/9781119968153 Search in Google Scholar

8. Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr, 2016;86(6):361-97.10.1159/000452150 Search in Google Scholar

9. Iotova V. Evaluation of growth in routine outpatient and clinical settings. Paediartic practice, 2004;4:7-8. Search in Google Scholar

10. Stanimirova N. Growth and development in adolescence: normal ranges and deviations. Dissertation, Medical University - Pleven, 1998. Search in Google Scholar

11. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur. J. Clin. Nutr, 1991;45(1):13-21. Search in Google Scholar

12. Darendeliler F, Lindberg A Wilton P. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency. Horm Res Paediatr, 2011;76 Suppl 1:42-6.10.1159/000329161 Search in Google Scholar

13. Antoniazzi F, Cavarzere P, Gaudino R. Growth hormone and early treatment. Minerva Endocrinol, 2015;40(2):129-43. Search in Google Scholar

14. Rappaport R, Mugnier Е, Limoni C, Crosnier H, Czernichow P, Leger J et al. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. J. Clin. Endocrinol. Metab, 1997;82(2):452-6. Search in Google Scholar

15. Stagi S, Scalini P, Farello G, Verrotti A. Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art. Ital. J. Pediatr, 2017;43(1):81. Search in Google Scholar

16. Thomas M, Massa G, Craen M, de Zegher F, Bourguignon JP, Heinrichs C et al. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001. Eur. J. Endocrinol, 2004;151(1):67-72. Search in Google Scholar

17. Lindsay R, Feldkamp M, Harris D, Robertson, Rallison J. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J. Pediatr, 1994;125(1):29-35.10.1016/S0022-3476(94)70117-2 Search in Google Scholar

18. Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS et al. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J. Clin. Endocrinol. Metab, 2013;98(6):E1072-E87.10.1210/jc.2012-3888378988623543664 Search in Google Scholar

19. Tsochev K, Stoycheva R, Iotova V, Karamfilova T, Markovska V, Halvadjian I et al. Results from the Implementation of a 2 Year Growth Awareness and Growth Disorders Screening Campaign (GrowInform). in 58th Annual ESPE. 2019. European Society for Paediatric Endocrinology. Search in Google Scholar

20. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab, 2006;91(10):3897-902.10.1210/jc.2006-055816849410 Search in Google Scholar

21. Maghnie M, Lindberg A, Koltowska-Haggstrom M Ranke MB. Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). Eur J Endocrinol, 2013;168(2):211-7.10.1530/EJE-12-080123152438 Search in Google Scholar

22. Collett-Solberg PF, Jorge AA, Boguszewski MC, Miller BS, Choong CSY, Cohen P et al. Growth hormone therapy in children; research and practice–A review. Growth Horm IGF Res, 2019;44:20-32.10.1016/j.ghir.2018.12.00430605792 Search in Google Scholar

23. Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS et al. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Horm Res Paediatr, 2019:1-14.10.1159/000502231697944331514194 Search in Google Scholar

24. Parra A, Argote RM, García G, Cervantes C, Alatorre S, Pérez-Pasten E. Body composition in hypopituitary dwarfs before and during human growth hormone therapy. Metab.: Clin. Exp, 1979;28(8):851-7. Search in Google Scholar

25. Boot AM, Engels MA, Boerma GJ, Krenning EP de Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J. Clin. Endocrinol. Metab, 1997;82(8):2423-8. Search in Google Scholar

26. Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab, 2010;95(3):1131-6.10.1210/jc.2009-1389284153720061431 Search in Google Scholar

27. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG and A.N.C.T. Group. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J. Clin. Endocrinol. Metab, 2002;87(1):90-8. Search in Google Scholar

28. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol, 2007;157(6):695-700.10.1530/EJE-07-063118057375 Search in Google Scholar

29. Akaltun I, Cayir A, Kara T Ayaydin H. Is growth hormone deficiency associated with anxiety disorder and depressive symptoms in children and adolescents?: A case-control study. Growth Horm IGF Res, 2018;41:23-7.10.1016/j.ghir.2018.06.00129886327 Search in Google Scholar

30. Silva N, Bullinger M, Sommer R, Rohenkohl A, Witt S Quitmann J. Children’s psychosocial functioning and parents’ quality of life in paediatric short stature: The mediating role of caregiving stress. Clin Psychol Psychother, 2018;25(1):e107-e18.10.1002/cpp.214628960605 Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo